Previous Close | 14.63 |
Open | 14.65 |
Bid | 14.00 x 1000 |
Ask | 16.66 x 1800 |
Day's Range | 13.98 - 14.68 |
52 Week Range | 11.12 - 62.34 |
Volume | |
Avg. Volume | 815,069 |
Market Cap | 670.91M |
Beta (5Y Monthly) | 1.91 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.78 |
Earnings Date | Nov 07, 2022 - Nov 11, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 27.50 |
Subscribe to Yahoo Finance Plus to view Fair Value for NSTG
SEATTLE, August 09, 2022--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a peer-reviewed paper published in Nature Genetics using the GeoMx Human Whole Transcriptome Atlas (WTA) to construct a high-resolution molecular landscape of pancreatic cancer. This paper, along with a tissue image generated using the GeoMx® Digital Spatial Profiler (DSP), is featured on the cover of the August 2022 edition of
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
The consensus price target hints at an 116.4% upside potential for NanoString (NSTG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.